Cisplatin/Fluorouracil/Tislelizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cisplatin, fluorouracil, and tislelizumab that may be used in the treatment of esophageal and esophagogastric junction cancers, and gastric cancer.

**Synonyms:** - Cisplatin-Fluorouracil-Tislelizumab - Cisplatin/Fluorouracil Plus Tislelizumab-jsgr - Cisplatin/Fluorouracil/Tevimbra - Cisplatin/Fluorouracil/Tislelizumab - Cisplatin/Fluorouracil/Tislelizumab-jsgr Regimen